This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Xudong Geng: Innovator in Cancer Research
Introduction
Xudong Geng is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly through his innovative patents. His work focuses on developing multi-antigenic constructs that can aid in cancer treatment.
Latest Patents
Xudong Geng holds a patent titled "Gp120 specific antigens and uses thereof." This invention provides multi-antigenic constructs comprising one or more carbohydrate antigens, which are crucial for advancing cancer therapies. He has 1 patent to his name, showcasing his commitment to innovation in medical science.
Career Highlights
Geng is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts groundbreaking research. His work at this prestigious institution has positioned him as a key player in the fight against cancer.
Collaborations
Some of his notable coworkers include Samuel J. Danishefsky and Vadim Y. Dudkin. Their collaborative efforts contribute to the advancement of cancer research and the development of new therapeutic strategies.
Conclusion
Xudong Geng's contributions to cancer research through his innovative patents highlight the importance of scientific collaboration and dedication to improving patient outcomes. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile